| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_471f57dc388cf17b48136aeb37201c6b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K125-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
| filingDate |
2018-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6c032f39906c30168f5e35e7af62c6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99f6800927bab32eb12cad1634f7afd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_784ab16a76ce89f80fcb024dc397bf12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4859a9cf57e752d2b1cab41eba08f3d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ce130f97289888837b5c41e07199990
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dfb9545506c519b0d0e0a26ee6e711f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e332b7f47393ed5514dd01bcea75d497 |
| publicationDate |
2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109498675-A |
| titleOfInvention |
Application of sage ganxi in the preparation of medicaments for preventing or treating pulmonary arterial hypertension |
| abstract |
Use of clary sage in the preparation of medicaments for preventing or treating pulmonary arterial hypertension. Experiments have shown that Clary Sage can significantly reduce the mean pulmonary arterial pressure in rats with elevated plateau hypoxic pulmonary arterial pressure, and has a significant effect on reducing right ventricular hypertrophy in rats. The invention provides a new medicine for preventing or treating pulmonary hypertension, and has better clinical application prospect. |
| priorityDate |
2018-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |